Medscape
The Medicines and Healthcare products Regulatory Agency ( MHRA) has removed postoperative pain relief from the licensed indications of prolonged-release morphine sulphate and prolonged-release oxycodone. The decision follows concerns over persistent postoperative opioid use (PPOU) and opioid-induced ventilatory impairment (OIVI). The announcement comes after a safety review by the MHRA…
Read More
MHRA Drops Post-Op Pain Use for Prolonged-Release Opioids
Buffy Mischke
22:19
The Medicines and Healthcare products Regulatory Agency ( MHRA) has removed postoperative pain relief from the licensed indications of prolonged-release morphine sulphate and prolonged-release oxycodone. The decision follows concerns over persistent postoperative opioid use (PPOU) and opioid-induced ventilatory impairment (OIVI). The announcement comes after a safety review by the MHRA…
